Alhambra Investment Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,983
Closed -$637K 171
2024
Q1
$637K Sell
7,983
-12,293
-61% -$939K 0.35% 79
2023
Q4
$1.6M Buy
20,276
+339
+2% +$24.1K 0.95% 26
2023
Q3
$1.39M Buy
19,937
+868
+5% +$61.5K 0.92% 30
2023
Q2
$1.32M Buy
19,069
+1,254
+7% +$89.2K 0.87% 30
2023
Q1
$1.32M Buy
17,815
+1,267
+8% +$106K 0.91% 29
2022
Q4
$1.54M Sell
16,548
-474
-3% -$45.7K 1.12% 23
2022
Q3
$1.62M Buy
17,022
+1,333
+8% +$132K 1.23% 18
2022
Q2
$1.45M Buy
15,689
+449
+3% +$43.8K 1.05% 24
2022
Q1
$1.54M Sell
15,240
-582
-4% -$61.1K 1.02% 23
2021
Q4
$1.63M Sell
15,822
-399
-2% -$36.9K 1.14% 19
2021
Q3
$1.38M Buy
16,221
+1,414
+10% +$118K 1.05% 25
2021
Q2
$1.24M Buy
14,807
+4,819
+48% +$395K 0.93% 25
2021
Q1
$751K Buy
9,988
+853
+9% +$62.1K 0.61% 44
2020
Q4
$624K Buy
9,135
+712
+8% +$46.3K 0.67% 48
2020
Q3
$492K Buy
+8,423
New +$524K 0.59% 53

Other funds holding CVS

Alhambra Investment Management's CVS Position: Q2 2024 in Review

Alhambra Investment Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 7,983 shares — an estimated $637K sold.

Alhambra Investment Management first reported a position in CVS in Q3 2020 and held it in 15 quarters. The position peaked at $1.63M in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Alhambra Investment Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Alhambra Investment Management sold 7,983 CVS Health shares in Q2 2024, an estimated $637K.
  • Alhambra Investment Management first reported a position in CVS Health in Q3 2020 and held it in 15 quarters.
  • Alhambra Investment Management's CVS Health position peaked at $1.63M in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Alhambra Investment Management's 13F filing for Q2 2024, filed 15 Jul 2024.